首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11085篇
  免费   1061篇
  国内免费   22篇
耳鼻咽喉   85篇
儿科学   403篇
妇产科学   167篇
基础医学   1603篇
口腔科学   358篇
临床医学   1239篇
内科学   2042篇
皮肤病学   237篇
神经病学   773篇
特种医学   682篇
外科学   1419篇
综合类   245篇
一般理论   4篇
预防医学   993篇
眼科学   200篇
药学   656篇
中国医学   14篇
肿瘤学   1048篇
  2021年   140篇
  2020年   91篇
  2019年   126篇
  2018年   165篇
  2017年   127篇
  2016年   139篇
  2015年   167篇
  2014年   208篇
  2013年   392篇
  2012年   450篇
  2011年   479篇
  2010年   302篇
  2009年   278篇
  2008年   403篇
  2007年   502篇
  2006年   447篇
  2005年   437篇
  2004年   443篇
  2003年   392篇
  2002年   376篇
  2001年   301篇
  2000年   336篇
  1999年   305篇
  1998年   215篇
  1997年   186篇
  1996年   169篇
  1995年   148篇
  1994年   135篇
  1993年   158篇
  1992年   284篇
  1991年   254篇
  1990年   223篇
  1989年   260篇
  1988年   189篇
  1987年   231篇
  1986年   208篇
  1985年   238篇
  1984年   154篇
  1983年   145篇
  1982年   120篇
  1981年   109篇
  1980年   114篇
  1979年   139篇
  1978年   105篇
  1977年   108篇
  1976年   114篇
  1975年   94篇
  1973年   93篇
  1972年   92篇
  1971年   92篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Infection is a common cause of morbidity and mortality in immunocompromised patients for whom diagnosis and management require scrupulous attention to detail and a continuing awareness of the micro-organisms causing infection in a particular environment in different groups of patients. Although uncommon and relatively non-pathogenic organisms may be the cause of infection in these patients most are caused by recognised pathogens. The present review concentrates on infection in the immunocompromised as seen in the United Kingdom.  相似文献   
992.
Some patients with severe symptomatic coronary artery disease despite maximal medical therapy are not eligible for bypass surgery or percutaneous coronary intervention, but may be eligible for two newer therapies: therapeutic angiogenesis with growth factors and transmyocardial laser revascularization.  相似文献   
993.
994.
Two patients are described in whom clinically significant red blood cell alloantibodies could be demonstrated only by in vivo 51chromium (51Cr) survival studies. The first patient had experienced a severe delayed hemolytic transfusion reaction to four units of crossmatch compatible blood. Serial phenotype studies suggested the presence of a serologically undetectable anti-c (hr') antibody. 51Cr survival of c- positive red blood cells was one per cent at 24 hours, while survival of c-negative red blood cells was 80 per cent at 24 hours. The second patient had multiple red blood cell alloantibodies. An anti-c antibody was suspected but could not be convincingly demonstrated by in vitro techniques. 51Cr survival of c-positive red blood cells, however, was 57 per cent at 24 hours and 17 per cent at 48 hours. 51Chromium red blood cell survival studies should be considered whenever an unexplained hemolytic transfusion reaction occurs, or when an expected red blood cell alloantibody cannot be demonstrated by in vitro laboratory studies.  相似文献   
995.
We have developed a simplified xylose assay procedure that requires only 10 min and requires 50 microL of serum or 5 microL of urine. The reaction with phloroglucinol is more sensitive than the classic p-bromaniline color reaction, and requires only 4 min of heating for color development. A single reagent is mixed with the specimen directly, without prior protein precipitation. Analytical recovery of xylose added to serum was quantitative; precision studies resulted in a between-day coefficient of variation of 5.2%. Glucose, which has significant potential for interference in most other xylose procedures, reacts under the test conditions only to the extent of 70 mumol of apparent xylose per liter for a 5.5 mmol/L solution of glucose. The new procedure has been valuable in the assessment of malabsorption, especially in children and infants, where serum xylose is the preferred measurement.  相似文献   
996.
997.
998.
The effect of prestorage irradiation on posttransfusion red cell survival   总被引:1,自引:0,他引:1  
Transfusion-associated graft-versus-host disease (TA-GVHD) may occur whenever immunologically competent allogeneic lymphocytes are transfused to an immunocompromised recipient. Irradiation of blood components eliminates the risk of TA-GVHD but may damage the cellular elements in the transfused component, particularly if the cells are stored for prolonged periods in the irradiated state. To study the effect of irradiation on long-term storage of red cells, AS-1 red cells from eight normal subjects were prepared on two occasions. On one occasion, the units were stored as standard AS-1 red cells for 42 days at 4 degrees C; on the other, they were exposed to 3000 cGy radiation within 4 hours of collection and then were stored as AS-1 red cells for 42 days at 4 degrees C. The donations were at least 12 weeks apart. Irradiated units demonstrated significant elevations in poststorage plasma hemoglobin (Hb) (623 +/- 206 vs. 429 +/- 194 g/dL [6230 +/- 2060 vs. 4290 +/- 1940 g/L], p less than 0.02) and plasma potassium (78 +/- 4 vs. 43 +/- 9 mEq/L [78 +/- 4 vs. 43 +/- 9 mmol/L], p less than 0.01) and significant decreases in red cell ATP (1.9 +/- 0.2 vs. 2.1 +/- 0.3 microM/g Hb, p less than 0.04) and 24-hour posttransfusion red cell recovery (68.5 vs. 78.4%, p less than 0.02), as compared to nonirradiated units. It can be concluded that irradiation with 3000 cGy damages red cells and that long-term storage in the irradiated state may enhance this damage. Red cells should not be stored for 42 days after irradiation with 3000 cGy.  相似文献   
999.
Detailed invasive haemodynamic studies were performed in 27of 32 patients with severe tetanus. Nineteen had severe uncomplicatedtetanus and eight had associated major complications, chieflyinfection and pulmonary complications. The results were comparedwith those obtained from 15 healthy male volunteers who servedas controls. There were two deaths in 32 patients (mortality6.25 per cent). Severe tetanus without major complications wascharacterized by a high output hyperkinetic circulatory statewith tachycardia (heart rate 131 (19.2) beats/minute), increasedstroke volume index (43.1 (10.7) ml/m2), increased cardiac index(5.48 (0.94)1/min/m2) and a normal left ventricular stroke workindex (60.5 (15.9) g/m/m2). Volume loading demonstrated a significanthaemodynamic response and increased vascular capacitance. Evenso the maximum percent rise from baseline values of these indicesafter volume load was significantly higher in controls (p <0.001). Autonomic cardiovascular disturbances affected bothsympathetic and parasympathetic activity. Hypertension and tachycardiaalternating with hypotension and bradycardia were related tosudden fluctuations in systemic vascular resistance. Our studiessuggested some degree of myocardial dysfunction in patientswith severe uncomplicated tetanus. The haemodynamics of severetetanus were masked and altered by complicating infection, pneumonia,and atelectasis.  相似文献   
1000.
A model for involutional bone loss   总被引:4,自引:0,他引:4  
Bone mass of the total skeleton and distal radius were measured by in vivo neutron activation analysis and single photon absorptiometry, respectively, in 403 healthy white women and 151 healthy white men. In addition, the density of L-2 to L-4 (bone mineral content of the spine [BMCs]) was measured by dual photon absorptiometry in 159 of these women and in 56 women with the vertebral crush fracture syndrome. The rate of loss of total body calcium (TBCa) and bone mineral content of the radius (BMCr) was linear in men and was slower than in women. The best fit for TBCa and the bone mineral content of the distal radius and spine as a function of age in women was with a two-phase regression. The TBCa and BMCr could be used as well as BMCs to identify women with crush fractures. The ratios of BMCs/TBCa, BMCs/BMCr, and TBCa/BMCr did not differ among women with crush fractures and age-matched normal individuals. Our data do not support the hypothesis that women with vertebral crush fractures have preferential loss of spinal bone.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号